Recruiting donors for stem cell research -National collaboration of hESC coordinators

Lead Research Organisation: King's College London
Department Name: Midwifery and Women's Health

Abstract

Human embryonic stem cells can be isolated from very early (6 days) developing embryos which have been grown in the laboratory as part of, or surplus to certain kinds of IVF treatment. Under certain conditions, these cells can be made to develop into different types of tissues, such as nerve or pancreas which it is hoped in the future, may be useful in treating degenerative diseases such as Parkinson s disease and diabetes, or in spinal injuries by replacing the diseased or damaged cells with healthy cells which have been grown in the laboratory. The number of embryonic stem cell lines that have been developed worldwide is still quite limited and further research is required to find out the best means to grow them in ways which will allow them to be safe for clinical use. In order to facilitate these developments, a National Stem Cell Bank has been established in the UK where stem cell lines can be deposited and stored, tested for safety, and then made available for research and clinical use. All stem cell derivation from embryos is strictly monitored in the UK and requires a licence from the Human Fertilisation and Embryology Authority. It is also a condition of licence that a sample of any suitable stem cell lines developed must sent to the UK Stem Cell Bank from where they are made available to research scientists in the UK and abroad
Deriving these embryonic stem cells ethically is critically dependent on identifying those patients who are prepared to donate to research any suitable embryos that are no longer needed for their IVF assisted conception treatment. In 2003 the MRC made funds available for the appointment of Nurse Coordinators, not involved directly in the stem cell derivation, who could counsel and advise patients that may be prepared to donate surplus embryos to stem cell programmes. They have been very successful and a number of lines have been submitted to the stem cell bank from this source. They have also established a UK network of stem cell coordinators (hESCCO) which facilitates their collaborative working and through which they have developed a national consent form for patients wishing to donate to stem cell research. The bid to the MRC is to continue funding of the nurse coordinators and their network.

Technical Summary

The UK has been able to establish a pre-eminent position in stem cell derivation and research due the presence of highly regulated but permissive legislation, strong support from government, and strategic support for the funding councils. The remit of the UK Stem Cell Bank, is to provide quality assured banks of stem cell lines suitable for use in clinical trials according to the demands of the Human Tissues and Cells Directive and applicable medicines regulation.
Ethical derivation of human embryonic stem cells is critically dependent on the availability of donated embryos obtained with transparent informed consent. Key to success is identifying patients prepared to donate embryos that are no longer needed for their assisted conception treatment using IVF, or from PGD centres that can generate lines containing specific clinically-relevant genetic defects.
As a result of the MRC strategic call in 2003 to facilitate and support interactions between IVF clinicians and research teams, some centres appointed nurses to facilitate the recruitment of patients who would be prepared to donate to stem cell research, fresh or frozen embryos surplus to their treatment. Through their efforts a number of fully characterised stem cell lines have been submitted to the bank. Although not yet under GMP conditions suitable for clinical use, they are available internationally for research purposes through the MRC Stem Cell Steering Committee.
Since the 2003 call, HFEA licence conditions now require a demonstrable separation between clinical and research decisions and information giving; hence the need for specific staff to fulfil this requirement if patient recruitment for stem cell generation is to continue.
One unique and positive outcome of the call has been the establishment of the UK Human Embryo Stem Cell Coordinators Network (hESCCO). With the support of the MRC, the coordinators have met biannually for a one-day meeting, which includes representatives of the MRC, HFEA and the UK stem cell bank. This collaborative working has enabled the development of a nationally agreed consent form for donation to stem cell generation, discussions over patient testing requirements with the regulators, sharing of information, recording of recruitment of patients to the various projects, and where appropriate, sharing of patients from different parts of the country who wish to donate.
The aim of this application is to seek refunding of these coordinators to continue the facilitation of donors to stem cell derivation programmes, and to fund the biannual hESCCO meetings.

Publications

10 25 50
 
Description Acad Med Sci report on interspecies hybrids
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
Impact Affected drafting of the revision Human Fertilisation and Embryology Act (2008)
 
Description Advisory Committee on Safety of Cells Tissues and Organs
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
Impact Member advising on testing and use of reproductive and stem cell tissues.
 
Description Cochrane guideline on embryo culture temperature
Geographic Reach Europe 
Policy Influence Type Membership of a guideline committee
 
Description ESHRE working group on the impact of embryo culture medium on long term health
Geographic Reach Europe 
Policy Influence Type Influenced training of practitioners or researchers
 
Description European human embryonic stem cell registry - hESCreg
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
Impact Provides information about what lines are available for distribution in Europe, their quality stage and particular characteristics which may be useful in developing lines for therapy
 
Description HFEA Information for Quality programme
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact acting as advisor to Human Fertilisation and Embryology Authority Information for quality programme which aims to improve regulatory oversight of the field including stem cell derivation, and improve information to patients and for delivery of clinical IVF services.
 
Description House of Commons Science and Technology Committee
Geographic Reach National 
Policy Influence Type Gave evidence to a government review
Impact Influenced demise of RATE and incorporation of stem cell and PGD clauses into HFE Act 2009. Changed policy on allowing embryos to be used for training as well as reserach
 
Description Influencing policy towards patenting of discoveries using hESC lines
Geographic Reach Europe 
Policy Influence Type Membership of a guideline committee
 
Description Japanese legal system
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a national consultation
Impact Will influence next revision of Japanese legislation on assisted conception, donor recruitment, and interaction with scientists engaging in stem cell research
 
Description Joint committee on the Human Tissue and Embryos (Draft) Bill
Geographic Reach National 
Policy Influence Type Gave evidence to a government review
Impact Contributed to the demise of joint HFEA/HTA ALB to be called RATE. Remained as separate bodies and stem cell derivation remained under HFEA
 
Description Member of TERMIS Scientific Advisory Board
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description Member of the HFEA Licensed Centres Panel
Geographic Reach National 
Policy Influence Type Membership of a guideline committee
Impact The licensed Centres Panel informs on HFEA procedures and policy. Specifically the panel discusses how improvements can be made, their impact and how best to implement these changes eg the requirement for clinics to increase the number of single embryo transfers performed in clinical IVF. This will obviously reduce the number of multiple births, which is the greatest health risk for women undergoing fertility treatment
 
Description Membership of HFEA's Scientific and Clinical Advances committee
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
Impact Advising the HFEA on changes in regulation on ART practice, embryology, embryonic stem cell biology
 
Description National Clinical human Embryonic Stem Cell Forum
Geographic Reach National 
Policy Influence Type Membership of a guideline committee
Impact Standardisation of requirements for clinical grade embryonic stem cell lines. Prof Brison is vice-chair of this group
 
Description Revision of Human Fertilisation and Embryology Act
Geographic Reach National 
Policy Influence Type Gave evidence to a government review
Impact Inclusion of stem cell science and use of human embryos as part of research practice in UK
 
Description Route Map for Stem Cell Regulation
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a national consultation
Impact Joint meeting of regulators to simplify processing of stem cell applications through HFEA, HTA, MHRA for clinical application
 
Description Setting standards for procurement of embryonic stem cells at clinical grade
Geographic Reach National 
Policy Influence Type Influenced training of practitioners or researchers
 
Description Stem Cells for Safer Medicine Panel Member
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description BBSRC icase studentship (with Argo)
Amount £110,000 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 01/2014 
End 12/2017
 
Description Chondrocytes from clinical grade embryonic stem cells
Amount £793,000 (GBP)
Funding ID MR/L004992/1 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 06/2014 
End 05/2017
 
Description Diabetes UK
Amount £570,000 (GBP)
Organisation Diabetes UK 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2015 
End 10/2018
 
Description EME - EFREEZE
Amount £700,000 (GBP)
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 08/2015 
End 07/2018
 
Description EME - HaBSelect
Amount £1,000,000 (GBP)
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 01/2014 
End 12/2015
 
Description EpiHealthNet
Amount € 285,607 (EUR)
Organisation European Commission 
Department Seventh Framework Programme (FP7)
Sector Public
Country European Union (EU)
Start 10/2013 
End 09/2016
 
Description MRC Research Grant (G0701172)
Amount £600,000 (GBP)
Funding ID G0701172 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 02/2009 
End 01/2012
 
Description MRC Research Grant (G0801061)
Amount £484,420 (GBP)
Funding ID G0801061 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 04/2009 
End 03/2012
 
Description MRC project grant
Amount £1,290,000 (GBP)
Funding ID MR/M017354/1 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 05/2015 
End 04/2017
 
Description NIHR Clinical fellowship
Amount £270,000 (GBP)
Organisation National Institutes of Health (NIH) 
Sector Public
Country United States
Start 06/2016 
End 05/2021
 
Description Refurbishment of IVF lab and stem cell laboratories
Amount £1,500,000 (GBP)
Organisation King's College London 
Sector Academic/University
Country United Kingdom
Start 01/2007 
End 12/2008
 
Description Toxicology programme
Amount £80,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 01/2015 
End 12/2018
 
Description UK national ART cohort - Population and Systems Medicine Board
Amount £200,000 (GBP)
Funding ID MR/L020335/1 
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 09/2014 
End 08/2016
 
Description Welcome biomedical ethics strategic award
Amount £800,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2009 
End 04/2014
 
Title Clinical grade hES cell lines 
Description We have derived 8 clincal grade hES cell lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133). 
Type Of Material Cell line 
Provided To Others? No  
Impact We are in process of depositing lines in UKSCB. When process is completed, the lines will be available to researchers worldwide. 
 
Title Human embryonic stem cell lines with clinically relevant mutations 
Description We have so far derived 22 lines carrying clinically relevant genetic mutations derived from affected embryos following preimplantation genetic diagnosis (PGD) (HFEA licence R0075) which includes cystic fibrosis (4 lines), Huntington's disease (7 lines), myotonic dystrophy type 1 (1 line), neurofibromatosis type 1 (2 lines), spinal muscular atrophy type 1 (1 line), Von Hippel-Lindau cancer syndrome (3 lines), ß-thalassemia (2 line), Wiskott-Aldrich syndrome and cystic fibrosis carrer (1 line), and Turner syndrome (1 line). 
Type Of Material Cell line 
Year Produced 2013 
Provided To Others? Yes  
Impact The cells are or will be deposited in the UK Stem Cell Bank. The deposition process is ongoing. The cell lines will be then be available to other researchers. The cell lines are also sumnitted to NIH Registry 
URL http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/hescell.aspx
 
Title Reseearch grade normal hES cel lines 
Description We have derived 9 lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133). 
Type Of Material Cell line 
Year Produced 2007 
Provided To Others? Yes  
Impact The cell lines are either submitted or in process of submission to UKSCB. They will be available to researchers worldwide. 
 
Description hESCCO 
Organisation Saint Mary's Hospital, Manchester
Department Department of Obstetrics and Gynaecology
Country United Kingdom 
Sector Hospitals 
PI Contribution Formation of a National network, human embryonic stem cell coordinators to facilitate collaboration of stem cell derivers, and their nurse coordinators.
Collaborator Contribution Knowledge transfer and experience
Impact Resulted in national consensus stem cell information leaflets and consent forms given to patients considering donating embryos for stem cell research. Please see G0700092 report for details of other outputs
 
Description hESCCO (Human Embryonic Stem Cell Coordinators) 
Organisation Saint Mary's Hospital, Manchester
Department Department of Obstetrics and Gynaecology
Country United Kingdom 
Sector Hospitals 
PI Contribution The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.
Collaborator Contribution Knowledge transfer and experience.Knowledge transfer and experience
Impact A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.
 
Description hESCCO (Human Embryonic Stem Cell Coordinators) 
Organisation Sheffield Teaching Hospitals NHS Foundation Trust
Department Assisted Conception Unit
Country United Kingdom 
Sector Hospitals 
PI Contribution The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.
Collaborator Contribution Knowledge transfer and experience.Knowledge transfer and experience
Impact A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.
 
Title A novel method of derivation of human embryonic stem cell lines 
Description A novel method of derivation of human embryonic stem cell lines. 
Type Support Tool - For Fundamental Research
Current Stage Of Development Initial development
Year Development Stage Completed 2011
Development Status Under active development/distribution
Impact Increased success rate at deriving stem cell lines. 
 
Title Protocol for genererating chondrocyte pro-genitor cells from embryonic stem cells 
Description protocol for deriving chondrocyte progenitor cells for cartilage repair. Next stage of work funded by MRC to translate protocol to clinical grade with pre-clinical animal testing 
Type Support Tool - For Fundamental Research
Current Stage Of Development Refinement. Non-clinical
Year Development Stage Completed 2010
Development Status Under active development/distribution
Impact impacts potential not yet realised 
 
Description 'Our Kid' Exhibition 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact Exhibition celebrating the 60th anniversary of the birth of the NHS in Manchester. Recorded interview with Daniel Brison on embryonic stem cells, one of 6 chosen areas of scientific excellence at the University of Manchester. Available to general public throughout mid-2008.

improved understanding of relationship between fertility treatment and stem cell research
Year(s) Of Engagement Activity 2008
 
Description Bioethics study day ~London 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Glenda Cornwell & Emma Stephenson Churches Together in England Bioethics Discussion Day: Stem Cells - What are they and why might they be useful?

Advising and discussing with church ideas of stem cell research and need for use of human embryos
Year(s) Of Engagement Activity 2007
 
Description British Embassy, Berlin 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact March 2009. Lecture on GMP human embryonic stem cells at DTI workshop.

HESCCO described and MRC support acknowledged, Summary reproduced in widely available handbook.
Year(s) Of Engagement Activity 2009
 
Description CMFT Xmas lecture 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Xmas Royal Society-style lecture for Central Manchester NHS Foundation Trust "The Stem Cell Revolution".

School visit requests
Year(s) Of Engagement Activity 2013
 
Description Embryologist national meeting 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Health professionals
Results and Impact Jan 09 - "Implications of donating embryos for stem cell research, ACE meeting, Edinburgh

Information for UK embryologists about stem cell research; need, and practical and ethical implications
Year(s) Of Engagement Activity 2009
 
Description Grammar school presentation 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Schools
Results and Impact February 2009 Stem Cells. Invited presentation at Stockport Grammar School as part of the Junior Cafesci programme.

Improved understanding in schools about embryonic stem cell reserach
Year(s) Of Engagement Activity 2009
 
Description Guardian newspaper article on ART child health 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Guardian newspaper article on ART child health
Year(s) Of Engagement Activity 2015
 
Description Infertility nurses meeting 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Health professionals
Results and Impact Glenda Cornwell Sept 07 - "Embryonic Stem Cell Research: The nurses role" National Fertility Nurse annual conference

Informing nurses involved in assisted conception units about need and use of surplus embryos for stem cell research
Year(s) Of Engagement Activity 2007
 
Description Institute of Physics 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Schools
Results and Impact Oldershaw RA. (June 2009) Invited guest speaker at the Institute of Physics (IoP) Manchester teacher's conference "Stem Cells - Hype and Hope".

This presentation was aimed to present an overview of the stem cell research being carried out at the University of Manchester in order that teachers can pass on to their students information about entering careers in science.
Year(s) Of Engagement Activity 2009
 
Description Invited lecture to EU Student Parliament debate on embryo research 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Undergraduate students
Results and Impact Invited lecture to EU Student parliament debate on human embryo research including embryonic stem cell derivation, in Salford, UK
Year(s) Of Engagement Activity 2016
 
Description Joint meeting of French and US embassies, center for American Progress stem cell workshop 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Meeting to examine science and differences in policies in UK, USA and France

Contributed to review of legislation in France, NIH review of ES science, and UK legislation.
Year(s) Of Engagement Activity 2007
 
Description Lancashire Humanists 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact 70 people attenced a public lecture on stem cell biology

Requests for other talks to Humanist groups.
Year(s) Of Engagement Activity 2013
 
Description Lecture to Tissue bankers 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Health professionals
Results and Impact Glenda Cornwell Apr 07 - "Embryonic stem cell donation: The hESCCO experience" British Association for Tissue Banking

Information to general tissue banking audience about recruiting donors to embryonic stem cell reserach Published abstract Abstracts from the Annual Scientific Meeting of the British Association for tissue banking
Year(s) Of Engagement Activity 2007
 
Description Manchester Science and Literature Festival 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact Workshop for general public at Manchester Central Library on IVF and stem cells

improved public understanding of stem cell reserach
Year(s) Of Engagement Activity 2008
 
Description Membership of HFEA's Information for Quality Programme 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Membership of HFEA's Information for Quality Programme
Year(s) Of Engagement Activity 2015
 
Description Membership of HFEA's Scientific and Clinical Advances Advisory Committee 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Membership of HFEA's Scientific and Clinical Advances Advisory Committee
Year(s) Of Engagement Activity Pre-2006,2006,2007,2008,
 
Description NIH hES consent revision 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact hESCCO consent form submitted and used by NIH in their re-evaluation of hES availability.

Likelihood that hESCCO consent form used to demonstrate that NIH proposed criteria have been in place in UK successfully since 2007
Year(s) Of Engagement Activity 2009
 
Description New Scientist Article on ART child health 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Interview for article in New Scientist on research into ART child health
Year(s) Of Engagement Activity 2016
 
Description Parliamentary and Scientific Committee (Human Reproductive Technologies) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Presentation to regular meeting of members or former members of Science and Technology Committee in House of Commons.

Influence thinking of key parliamentarians on Human Fertilisation and Embryology Bill revision
Year(s) Of Engagement Activity 2006
 
Description Progress Educational Trust Meeting; ethics legal and social issues of stem cells 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact Key speaker in symposium for public and interested science groups - Putting stem cells into practice: ethical, legal and social issues.

Increased understanding or stem cell science and its relevance to science and health.
Year(s) Of Engagement Activity 2006
 
Description Public Lecture Oxford 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact May 2009 - Oxford May Music series- Human embryonic stem cells; Strings attached. General audience in science and music series.

Increased awareness of achievements of stem cell research and need for use of eggs and embryos
Year(s) Of Engagement Activity 2008
 
Description Radio 4 interview re 'Promising' stem cell trials for blindness 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Daniel Brison interviewed and commented on news story re stem cell therapies

Raising public awareness
Year(s) Of Engagement Activity 2012
 
Description Radio 4 interview with Mark Porter 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Sue Kimber interviewed on Radio 4 Case Notes programme re stem cell therapies

Raised public awareness, led to doubled patient and GP interest in NWESCC
Year(s) Of Engagement Activity 2012
 
Description Radio interview manchester 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact June 2009 Channel M Interview on Embryonic stem cells. BBC radio Manchester live interview on Embryonic stem cells

Improved public understanding of stem cells
Year(s) Of Engagement Activity 2009
 
Description Science Media Centre press conference 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? Yes
Type Of Presentation Keynote/Invited Speaker
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Press conference organised by SMC to discuss press release concerning submission of clinical grade embryonic stem cell lines to the UK Stem Cell Bank

Interest from media, followup stories. Followup contacts from industry resulting directly from press release.
Year(s) Of Engagement Activity 2011
 
Description Visit of delegation from US senate and Congress 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Participated in fact finding mission by supporters and sceptics of stem cell science from US to the UK.

Will have had an impact on voting in Stem cell issues in USA
Year(s) Of Engagement Activity 2006
 
Description Westminster forum 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Peter Braude and Alison Murdoch Oct 2007 The Future of regulation - Westminster Health Forum Seminar, Regulation with compassion

Invited parliamentarians and policy makers discussion and debate; document produced
Year(s) Of Engagement Activity 2007
 
Description hESCCO website 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact Set up a website for internal communication for coordinators and for use by patients for links and informatino etc.

None
Year(s) Of Engagement Activity 2008
 
Description publication 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Primary Audience Health professionals
Results and Impact Publication from the hESCCO group

None
Year(s) Of Engagement Activity 2008
 
Description video clip on BBC website 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact SERIES: Health Explained
TITLE: How to make stem cells
DATE OF PUBLICATION: 21 Jun 2012
URL: www.bbc.co.uk/news/health-18496355

promoting our research
Year(s) Of Engagement Activity 2012